PART 11 Transitional provision in relation to the abolition of clinical commissioning groups and the creation of integrated care boards

Transitional provision: NHS England’s financial responsibilities

34.  In respect of the financial year ending with 31st March 2023—

(a) section 223C of the 2006 Act(1) is to be read as if—

(i) the list of bodies in subsection (1) included a reference to clinical commissioning groups in respect of their expenditure incurred and sums received in the period beginning with the 1st April 2022 and ending with the 30th June 2022;

(ii) subsection (2)(d) included a reference to sums received but not spent by a predecessor clinical commissioning group in the period beginning with 1st April 2022 and ending with 30th June 2022 to be aggregated with any sums received but not spent by the integrated care board;

(b) section 223D of the 2006 Act(2) is to be read as if the list of bodies in subsection (3) included a reference to clinical commissioning groups in respect of their use of capital resources or (as the case may be) revenue resources in the period beginning with 1st April 2022 and ending with 30th June 2022;

(c) section 223E of the 2006 Act(3) is to be read as if—

(i) subsection (2) included a reference to clinical commissioning groups in respect of their use of capital resources or (as the case may be) revenue resources in the period beginning with 1st April 2022 and ending with 30th June 2022;

(ii) subsection (3) included a reference to NHS England’s use of revenue resources which is attributable to such matters relating to administration as are specified in the direction in connection with clinical commissioning groups in the period beginning with 1st April 2022 and ending with 30th June 2022.

(1)

Section 223C is substituted by sections 27 and 28 of the 2022 Act.

(2)

Section 223D is substituted by section 27 of the 2022 Act.

(3)

Section 223E is substituted by section 27 of the 2022 Act.